Lawrence N. Kwong

15.3k citations

62 papers · 2.6k indexed · 1 hit paper · h-index 27

Molecular Biology top 5%
Oncology top 2%
Cancer Research top 5%
Pulmonary and Respiratory Medicine top 5%
Surgery top 10%

Co-authors: William F. Dove Michael A. Davies Lynda Chin Gabriele Romano Milind Javle Keith T. Flaherty Scott W. Lowe Joerg Heyer
Topics: Cancer Genomics and Diagnostics (18 papers)Melanoma and MAPK Pathways (17 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers)
Cited by: Oncology Cancer Research Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation Nature Medicine
Partner nations: United States China Austria

In The Last Decade

Lawrence N. Kwong

61 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics

2022 181 citations Ping Song, Lucia R. Wu et al. Nature Biomedical Engineering profile →

Peers

Countries citing papers authored by Lawrence N. Kwong

Since Specialization

Citations

This map shows the geographic impact of Lawrence N. Kwong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence N. Kwong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence N. Kwong more than expected).

Fields of papers citing papers by Lawrence N. Kwong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence N. Kwong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence N. Kwong. The network helps show where Lawrence N. Kwong may publish in the future.

Co-authorship network of co-authors of Lawrence N. Kwong

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence N. Kwong. A scholar is included among the top collaborators of Lawrence N. Kwong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence N. Kwong. Lawrence N. Kwong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma 2023 ·Cancer Immunology Research ·Gabriele Romano,Francesca Paradiso,(unknown),(unknown),(unknown),(unknown),John P. Miller,Roger J. Liang,Timothy L. Helms,Alexander J. Lazar,Jennifer A. Wargo,Francesca Taraballi,James C. Costello,Lawrence N. Kwong	4
2	Abstract 3893: KRAS G12C colon cancer resistance to vertical MAPK inhibition converges on FOS-JUN signaling through orthogonal mechanisms 2023 ·Cancer Research ·(unknown),Lawrence N. Kwong	2
3	Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma 2023 ·Journal of Investigative Dermatology ·(unknown),Mariana Petaccia de Macêdo,Fernando C. L. Carapeto,Feng Wang,Diego M. Marzese,Khalida Wani,Lauren E. Haydu,Weiyi Peng,Giang T. Ong,Sarah Warren,Joseph Beechem,Dave S.�B. Hoon,Gordon B. Mills,Michael T. Tetzlaff,Alexander J. Lazar,Lawrence N. Kwong,Michael A. Davies	3
4	Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma 2023 ·Journal of Hepatology ·Timothy P. DiPeri,Ming Zhao,Kurt W. Evans,(unknown),(unknown),Stephen Scott,Michael Kahle,(unknown),Huiqin Chen,Sunyoung S. Lee,Abdel‐Baset Halim,Hiroshi Hirai,Volker Wacheck,Lawrence N. Kwong,Jordi Rodón,Milind Javle,Funda Meric‐Bernstam	18
5	Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6 2022 ·Cancer Research ·Alexey V. Sorokin,Preeti Kanikarla Marie,(unknown),(unknown),(unknown),Ganiraju C. Manyam,Lawrence N. Kwong,Benny Johnson,Van K. Morris,Philip Jones,David G. Menter,Michael S. Lee,Scott Kopetz	37
6	Comprehensive microRNA analysis across genome-edited colorectal cancer organoid models reveals miR-24 as a candidate regulator of cell survival 2022 ·BMC Genomics ·(unknown),Lawrence N. Kwong,Teng Han,(unknown),Michael T. Shanahan,Matt Kanke,Lukas E. Dow,Charles G. Danko,Praveen Sethupathy	2
7	Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnosticsbreakdown → 2022 ·Nature Biomedical Engineering ·Ping Song,Lucia R. Wu,Yan Helen Yan,Jinny Xuemeng Zhang,Tianqing Chu,Lawrence N. Kwong,Abhijit A. Patel,David Y. Zhang	181
8	High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens 2021 ·Scientific Reports ·(unknown),Lauren E. Haydu,Ping Song,(unknown),Michael T. Tetzlaff,Lawrence N. Kwong,Jeffrey E. Gershenwald,Michael A. Davies,David Y. Zhang	17
9	Oncogene Concatenated Enriched Amplicon Nanopore Sequencing for rapid, accurate, and affordable somatic mutation detection 2021 ·Genome biology ·(unknown),(unknown),Ping Song,(unknown),Mitesh J. Borad,Lawrence N. Kwong,Phillip James,Daniel J. Turner,David Y. Zhang	16
10	In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms 2018 ·Cancer Discovery ·Jessica L.F. Teh,Phil F. Cheng,Timothy J. Purwin,Neda Nikbakht,Prem Patel,Inna Chervoneva,Adam Ertel,Paolo Fortina,(unknown),Kim HooKim,Michael A. Davies,Lawrence N. Kwong,Mitch P. Levesque,Reinhard Dummer,Andrew E. Aplin	61
11	Crosstalk between the Notch signaling pathway and long non-coding RNAs 2018 ·Cancer Letters ·(unknown),(unknown),Lawrence N. Kwong,Martin Pichler	27
12	Accurate quantification of PGE2 in the polyposis in rat colon (Pirc) model by surrogate analyte-based UPLC–MS/MS 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown),Wan‐Mohaiza Dashwood,Lawrence N. Kwong,Song Gao,Taijun Yin,(unknown),Rashim Singh,Roderick H. Dashwood,Ming Hu	10
13	Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice 2016 ·Current Treatment Options in Oncology ·Apurva Jain,Lawrence N. Kwong,Milind Javle	94
14	Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression 2016 ·Scientific Reports ·Jason Roszik,Chang‐Jiun Wu,Alan Siroy,Alexander J. Lazar,Michael A. Davies,Scott E. Woodman,Lawrence N. Kwong	8
15	Chromosome 10, Frequently Lost in Human Melanoma, Encodes Multiple Tumor-Suppressive Functions 2014 ·Cancer Research ·Lawrence N. Kwong,Lynda Chin	16
16	Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma 2012 ·Nature Medicine ·Lawrence N. Kwong,James C. Costello,Huiyun Liu,Shan Jiang,Timothy L. Helms,Aliete Langsdorf,David Jakubosky,Giannicola Genovese,Florian L. Müller,Joseph H. Jeong,Ryan Bender,Gerald C. Chu,Keith T. Flaherty,Jennifer A. Wargo,(unknown),Lynda Chin	274
17	APC and Its Modifiers in Colon Cancer 2009 ·Advances in experimental medicine and biology ·Lawrence N. Kwong,William F. Dove	182
18	A target-selected Apc -mutant rat kindred enhances the modeling of familial human colon cancer 2007 ·Proceedings of the National Academy of Sciences ·James Amos‐Landgraf,Lawrence N. Kwong,Christina Kendziorski,Mark Reichelderfer,José Torrealba,Jamey P. Weichert,Jill D. Haag,(unknown),(unknown),Michael N. Gould,William F. Dove	109
19	Atm is a negative regulator of intestinal neoplasia 2007 ·Oncogene ·Lawrence N. Kwong,K. R. Weiss,Kevin M. Haigis,William F. Dove	15
20	Growth Factors and Oncogenes as Targets in Melanoma: Lost in Translation? 2007 ·PubMed ·Lawrence N. Kwong,Lynda Chin,Stephan N. Wagner	14

About Lawrence N. Kwong

Lawrence N. Kwong is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 62 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (18 papers), Melanoma and MAPK Pathways (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (641 citations) and Molecular Biology (1.5k citations). Lawrence N. Kwong has collaborated with scholars based in United States, China and Austria. Frequent co-authors include William F. Dove, Michael A. Davies, Lynda Chin, Gabriele Romano, Milind Javle, Keith T. Flaherty, Scott W. Lowe, Joerg Heyer, Apurva Jain and Jennifer A. Wargo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact